News

Biotech Behemoths in Review

"the average time to an initial exit for the [tech] titans (8.2 +/-2.1 years) was considerably longer than that for the [biotech] behemoths ( ~4.7 +/- 2.7 years)."

Shifting tide of public opinion: The more Americans know about gene editing, the more likely they are to deem it safe to use in agriculture

"People who have heard or read a lot about gene editing generally have a favorable opinion about using it for agricultural or medical purposes"

Why the global bioeconomy urgently needs technical standards and metrics

"The global bioeconomy is estimated to be worth about $4 trillion, with more than 50 nations having published bioeconomy strategies."

Unlock Deeper Insights of Somatic Mutations with Deep Learning

"NVIDIA Parabricks expands the NVIDIA emphasis on solving omics challenges with deep learning and continues accelerating genomics instruments"

AlphaFold 3, CRISPR Eyes, Ear Genes, MDMA, Societal Collapse

"We are living in an age of miracles."

Democratize Omics Data Analysis with Basepair on AWS HealthOmics

Amazon Web Services' focus on genomics (and proteomics, transcriptomics, etc.) is evidence that the industry is digital and big.

Personal Hygiene’s Renaissance, Brought to You by Synthetic Biology

"[I]t’s so delightful that Taxa Technologies will be using synthetic biology to get their consumers closer to nature, not further. In other words, they’ll be leveraging synthetic biology to deliver products that are actually less synthetic"

Synthetic Biology Market Experiencing Rapid Growth 28.3%

"The synthetic biology market is experiencing rapid growth driven by its diverse applications across medicine, manufacturing, and agriculture."

5 Startup Opportunities In Genomics

"The ability to read, interpret, and manipulate genetic information is not just transforming medicine by offering the potential to eliminate diseases and increase human lifespan - it's paving the way for entirely new industries."

Proteomics sets up single-cell and single-molecule solutions

"The future is not one in which every biologist has to be a mass spectrometrist"

The U.S. Bioeconomy: Charting a Course for a Resilient and Competitive Future

"Schmidt Futures, a philanthropic initiative of Eric and Wendy Schmidt, convened a Task Force to chart a course for achieving the promise of platform technologies such as engineering biology and artificial intelligence to contribute to what has recently been projected to become a future bioeconomy worth somewhere between $4 trillion and $30 trillion dollars globally, according to the most recent projections."

Safeguarding the Bioeconomy

"Moving forward, the life sciences communities will likely continue to experience change in the form of growing transdisciplinary and team-based science; an increasing shift toward applying engineering approaches to biology; a global environment for science that is driven by sharing, accessing, and analyzing large amounts of data; and changing stakeholders, workforce, and supply chains."